BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 31575425)

  • 1. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report.
    Narang N; Medvedofsky D; Dryer K; Shah SJ; Davidson CJ; Patel AR; Blair JEA
    ESC Heart Fail; 2017 Nov; 4(4):645-648. PubMed ID: 29154426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.
    Wei J; Nelson MD; Szczepaniak EW; Smith L; Mehta PK; Thomson LE; Berman DS; Li D; Bairey Merz CN; Szczepaniak LS
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H14-9. PubMed ID: 26519031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.
    Gao C; Tao Y; Pan J; Shen C; Zhang J; Xia Z; Wan Q; Wu H; Gao Y; Shen H; Lu Z; Wei M
    Eur Radiol; 2019 May; 29(5):2360-2368. PubMed ID: 30631923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction.
    Markley R; Del Buono MG; Mihalick V; Pandelidis A; Trankle C; Jordan JH; Decamp K; Winston C; Carbone S; Billingsley H; Barron A; Thomas G; Van Tassell B; Hundley WG; Kellman P; Abbate A
    Int J Cardiovasc Imaging; 2023 Apr; 39(4):811-819. PubMed ID: 36607469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast long-axis strain: a simple, automatic approach for assessing left ventricular longitudinal function with cine cardiovascular magnetic resonance.
    Leng S; Tan RS; Zhao X; Allen JC; Koh AS; Zhong L
    Eur Radiol; 2020 Jul; 30(7):3672-3683. PubMed ID: 32107604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.
    Kucukseymen S; Neisius U; Rodriguez J; Tsao CW; Nezafat R
    Int J Cardiovasc Imaging; 2020 Oct; 36(10):2027-2038. PubMed ID: 32533279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Chirinos JA; Bhattacharya P; Kumar A; Proto E; Konda P; Segers P; Akers SR; Townsend RR; Zamani P
    J Am Heart Assoc; 2019 Feb; 8(4):e011457. PubMed ID: 30764699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
    J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between diffuse fibrosis assessed by CMR and depressed myocardial strain in different stages of heart failure.
    Zhang Y; Zhang X; Wang Y; Hu X; Wang B; Yang J; Zhao X; Zhang L
    Eur J Radiol; 2023 Jul; 164():110848. PubMed ID: 37156180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Left Ventricular Strain by Cardiac Magnetic Resonance Feature-Tracking to Predict Cardiovascular Events in Patients With and Without Heart Failure.
    Sardana M; Konda P; Hashmath Z; Oldland G; Gaddam S; Miller R; Satija V; Ansari B; Lee J; Mustafa A; Akers SR; Chirinos JA
    Am J Cardiol; 2019 Apr; 123(8):1301-1308. PubMed ID: 30717885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.